These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 12428723

  • 1. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease.
    Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT, Checkoway H.
    Neurotoxicology; 2002 Oct; 23(4-5):515-9. PubMed ID: 12428723
    [Abstract] [Full Text] [Related]

  • 2. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.
    Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H.
    J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):535-7. PubMed ID: 10990520
    [Abstract] [Full Text] [Related]

  • 3. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease.
    Costa-Mallen P, Checkoway H, Fishel M, Cohen AW, Smith-Weller T, Franklin GM, Swanson PD, Costa LG.
    Neurosci Lett; 2000 Jan 07; 278(1-2):33-6. PubMed ID: 10643794
    [Abstract] [Full Text] [Related]

  • 4. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.
    Costa-Mallen P, Costa LG, Checkoway H.
    Neurosci Lett; 2005 Sep 09; 385(2):158-62. PubMed ID: 15955630
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: a study in an Asian population.
    Tan EK, Chai A, Lum SY, Shen H, Tan C, Teoh ML, Yih Y, Wong MC, Zhao Y.
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jul 01; 120B(1):58-62. PubMed ID: 12815741
    [Abstract] [Full Text] [Related]

  • 6. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.
    Zhang Y, Piao X, Wu J, Li Y, Liang Q.
    Int J Neurosci; 2016 Jul 01; 126(5):400-7. PubMed ID: 26000819
    [Abstract] [Full Text] [Related]

  • 7. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease.
    Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG.
    Am J Med Genet; 1997 Apr 18; 74(2):154-6. PubMed ID: 9129714
    [Abstract] [Full Text] [Related]

  • 8. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease.
    Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa LG.
    Neurology; 1998 May 18; 50(5):1458-61. PubMed ID: 9596006
    [Abstract] [Full Text] [Related]

  • 9. [The EcoR V polymorphism of human monoamine oxidase A is not associated with idiopathic Parkinson's disease in a Shanghai Han population].
    Xie H, Wang X, Hao Y, Tang G, Xu L, Wu Q, Chen L, Ren D.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug 18; 19(4):329-31. PubMed ID: 12170473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
    Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson's Disease Study Group.
    BMC Neurol; 2011 Jul 25; 11():89. PubMed ID: 21781348
    [Abstract] [Full Text] [Related]

  • 15. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men.
    Pivac N, Knezevic J, Mustapic M, Dezeljin M, Muck-Seler D, Kozaric-Kovacic D, Balija M, Matijevic T, Pavelic J.
    Life Sci; 2006 May 30; 79(1):45-9. PubMed ID: 16427095
    [Abstract] [Full Text] [Related]

  • 16. [Polymorphism of MAO-B gene and NAD(P)H: quinone oxidoreductase gene in Parkinson's disease].
    Shao M, Liu Z, Tao E, Chen B.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr 30; 18(2):122-4. PubMed ID: 11295131
    [Abstract] [Full Text] [Related]

  • 17. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.
    Pivac N, Knezevic J, Kozaric-Kovacic D, Dezeljin M, Mustapic M, Rak D, Matijevic T, Pavelic J, Muck-Seler D.
    J Affect Disord; 2007 Nov 30; 103(1-3):131-8. PubMed ID: 17289152
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers.
    McKinney EF, Walton RT, Yudkin P, Fuller A, Haldar NA, Mant D, Murphy M, Welsh KI, Marshall SE.
    Pharmacogenetics; 2000 Aug 30; 10(6):483-91. PubMed ID: 10975602
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.